Parkinson's disease (PD) is a progressive movement disorder caused by the death of dopamine-producing cells in the midbrain. There is a need for frequent symptom assessment, since the treatment needs to be individualized as the disease progresses. The aim of this paper was to verify and further investigate the clinimetric properties of an entropy-based method for measuring PD-related upper limb temporal irregularities during spiral drawing tasks. More specifically, properties of a temporal irregularity score (TIS) for patients at different stages of PD, and medication time points were investigated. Nineteen PD patients and 22 healthy controls performed repeated spiral drawing tasks on a smartphone. Patients performed the tests before a sing...
In this study, we quantify the severity of drug-induced dyskinesias in the arms of Parkinson's disea...
Objective: To investigate whether spirography-based objective measures are able to effectively chara...
<div><p>Introduction</p><p>Pre-clinical markers of Parkinson’s Disease (PD) are needed, and to be re...
Parkinson's disease (PD) is a progressive movement disorder caused by the death of dopamine-producin...
Parkinson’s disease (PD) is a progressive movement disorder caused by the death of dopamine-producin...
The objective of this paper was to develop and evaluate clinimetric properties of a method for measu...
-value = 0.02). Test-retest reliability of TIS was good with Intra-class Correlation Coefficient of ...
OBJECTIVES: To develop a method for objective assessment of fine motor timing variability in Parkins...
International audienceOne of the current scientific challenges is to propose novel tools and tasks d...
In this study, we quantify the severity of drug-induced dyskinesias in the arms of Parkinson's disea...
A challenge for the clinical management of advanced Parkinson’s disease (PD) patients is the emergen...
A challenge for the clinical management of advanced Parkinson’s disease (PD) patients is the emergen...
A challenge for the clinical management of advanced Parkinson’s disease (PD) patients is the emergen...
Background: A mobile device test battery, consisting of a patient diary collection section with dise...
IntroductionPre-clinical markers of Parkinson's Disease (PD) are needed, and to be relevant in pre-c...
In this study, we quantify the severity of drug-induced dyskinesias in the arms of Parkinson's disea...
Objective: To investigate whether spirography-based objective measures are able to effectively chara...
<div><p>Introduction</p><p>Pre-clinical markers of Parkinson’s Disease (PD) are needed, and to be re...
Parkinson's disease (PD) is a progressive movement disorder caused by the death of dopamine-producin...
Parkinson’s disease (PD) is a progressive movement disorder caused by the death of dopamine-producin...
The objective of this paper was to develop and evaluate clinimetric properties of a method for measu...
-value = 0.02). Test-retest reliability of TIS was good with Intra-class Correlation Coefficient of ...
OBJECTIVES: To develop a method for objective assessment of fine motor timing variability in Parkins...
International audienceOne of the current scientific challenges is to propose novel tools and tasks d...
In this study, we quantify the severity of drug-induced dyskinesias in the arms of Parkinson's disea...
A challenge for the clinical management of advanced Parkinson’s disease (PD) patients is the emergen...
A challenge for the clinical management of advanced Parkinson’s disease (PD) patients is the emergen...
A challenge for the clinical management of advanced Parkinson’s disease (PD) patients is the emergen...
Background: A mobile device test battery, consisting of a patient diary collection section with dise...
IntroductionPre-clinical markers of Parkinson's Disease (PD) are needed, and to be relevant in pre-c...
In this study, we quantify the severity of drug-induced dyskinesias in the arms of Parkinson's disea...
Objective: To investigate whether spirography-based objective measures are able to effectively chara...
<div><p>Introduction</p><p>Pre-clinical markers of Parkinson’s Disease (PD) are needed, and to be re...